OpenAlex
PricingAboutJobs
Log inGet started
Work

Current approaches and future directions in the treatment of HER2-positive breast cancer

HTML

Year: 2012
Type: review
Source: Cancer Treatment Reviews
DOI: 10.1016/j.ctrv.2012.04.008
Authors: Sara A. Hurvitz, Yufang Hu, Neil O’Brien, Richard S. Finn
Institution: University of California, Los Angeles
Language: English

Topic: HER2/EGFR in Cancer Research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: HER2-positive breast cancer, HER2 amplification, trastuzumab, lapatinib, drug resistance, receptor cross-talk, autophagy, PI3K inhibition, mTOR inhibition, neoangiogenesis, vascular endothelial growth factor, antibody-drug conjugates, combination therapy, tyrosine kinase inhibitors
SDG: Good health and well-being

Open Access status: green

Funders: Novartis Pharmaceuticals Corporation, National Institutes of Health, National Cancer Institute, National Center for Research Resources, National Center for Advancing Translational Sciences
Awards: UCLA Clinical and Translational Science Institute, G2663518188, G2667433385, UCLA Clinical and Translational Science Institute, Cancer Center Support Grant
OpenAlex ID: W2080550759
FWCI: 2.254
Cites: 120
Cited by: 168
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security